tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).
Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 37.5% that have a potential upside of 79.8% achieved within 127 days.
Catherine Novack’s has documented 28 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CAPR, Capricor Therapeutics at 24-Jun-2025.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 8/9/2024. The price target of $12 was fulfilled within 68 days with a profit of $6.59 (121.81%) receiving and performance score of 17.91.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 18-Dec-2020
$12
$10.02 (506.06%)
$12
1 months 9 days ago
(02-Dec-2025)
0/6 (0%)
$10.28 (597.67%)
Buy
Since 04-Sep-2025
$8
$6.02 (304.04%)
4 months 7 days ago
(04-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
660
Buy
Since 16-Aug-2024
$13
$11.02 (556.57%)
1 years 4 months 26 days ago
(16-Aug-2024)
0/1 (0%)
$9.43 (264.15%)
Buy
$3
$0.09 (3.09%)
1 years 7 months 28 days ago
(15-May-2024)
2/2 (100%)
$-1.32 (-30.56%)
135
Buy
Since 30-Aug-2023
$2
$0.02 (1.01%)
2 years 4 months 12 days ago
(30-Aug-2023)
1/1 (100%)
$-6.52 (-76.53%)
709
What Year was the first public recommendation made by Catherine Novack?
